• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有磷尿性间叶肿瘤和骨纤维发育不良患者低磷血症病因的确定方法。

Approach to determining etiology of hypophosphatemia in a patient with coexisting phosphaturic mesenchymal tumor and fibrous dysplasia.

作者信息

Patil Madhuri D, Wangsiricharoen Sintawat, Lazar Alexander J, Moon Bryan, Madewell John E, Collins Michael T, Guise Theresa A

机构信息

Division of Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX 77030, United States.

Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.

出版信息

JBMR Plus. 2024 Nov 15;9(1):ziae145. doi: 10.1093/jbmrpl/ziae145. eCollection 2025 Jan.

DOI:10.1093/jbmrpl/ziae145
PMID:39664934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11631047/
Abstract

Dysregulated FGF23 production is a demonstrated cause of hypophosphatemia and osteomalacia. Diseases associated with these conditions include phosphaturic mesenchymal tumor (PMT) causing tumor induced osteomalacia, various forms of rickets, and fibrous dysplasia (FD). Coexistence of 2 conditions that can increase FGF23 concentrations is rare. We report a case of a 79-yr-old man who presented with rib and right flank pain. Imaging revealed bone lesions in the right iliac wing, left supra-acetabular area, and L4 vertebral body. Biopsies showed a right iliac PMT and left supra-acetabular FD. Cryoablation of both lesions resolved the phosphaturia with normalization of phosphorus level. Coexistence of PMT and FD in this patient with hypophosphatemia raised questions about the source of the FGF23, meaning of coexistence of PMT and FD in the same patient and, about the nature of the third lesion in the L4 vertebral body. Using FGF23 mRNA chromogenic in situ hybridization, we identified the PMT, rather than the FD, as the source of FGF23. Lack of mutation in the PMT suggested it being independent of FD. Assessment by the intact FGF23: total FGF23 ratio as well as gallium-DOTATATE scan suggested that the vertebral body lesion could represent FD. Other than understanding difference in underlying molecular processing of FGF23 in PMT and FD, testing for mutations, imaging studies as well as in situ hybridization helped solve the questions arising from this unique case of coexistence of PMT and FD.

摘要

成纤维细胞生长因子23(FGF23)生成失调是低磷血症和骨软化症的一个已证实病因。与这些病症相关的疾病包括导致肿瘤性骨软化症的磷酸尿性间叶肿瘤(PMT)、各种形式的佝偻病以及骨纤维发育不良(FD)。两种可增加FGF23浓度的病症同时存在的情况较为罕见。我们报告一例79岁男性患者,其表现为肋骨和右胁腹疼痛。影像学检查显示右髂骨翼、左髋臼上区域和L4椎体有骨病变。活检显示右髂骨为PMT,左髋臼上为FD。对两个病变进行冷冻消融后,磷尿症得到缓解,磷水平恢复正常。该低磷血症患者同时存在PMT和FD,引发了关于FGF23来源、同一患者中PMT和FD同时存在的意义以及L4椎体第三个病变性质的问题。通过FGF23 mRNA显色原位杂交,我们确定PMT而非FD是FGF23的来源。PMT缺乏突变表明它与FD无关。通过完整FGF23与总FGF23比值评估以及镓-奥曲肽扫描表明椎体病变可能代表FD。除了了解PMT和FD中FGF23潜在分子加工的差异外,突变检测、影像学研究以及原位杂交有助于解决这例PMT和FD同时存在的独特病例所引发的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/087b8d005cd2/ziae145f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/c04bd7376ad8/ziae145f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/433d13820e84/ziae145f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/2286047a9584/ziae145f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/035c6caedcc6/ziae145f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/087b8d005cd2/ziae145f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/c04bd7376ad8/ziae145f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/433d13820e84/ziae145f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/2286047a9584/ziae145f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/035c6caedcc6/ziae145f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d82/11631047/087b8d005cd2/ziae145f5.jpg

相似文献

1
Approach to determining etiology of hypophosphatemia in a patient with coexisting phosphaturic mesenchymal tumor and fibrous dysplasia.伴有磷尿性间叶肿瘤和骨纤维发育不良患者低磷血症病因的确定方法。
JBMR Plus. 2024 Nov 15;9(1):ziae145. doi: 10.1093/jbmrpl/ziae145. eCollection 2025 Jan.
2
Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.隐匿于众目睽睽之下:基因检测板和遗传标记揭示了一例长达26年未被诊断出的肋骨肿瘤诱导性骨软化症,该病例同时被误诊为X连锁低磷血症。
Bone Rep. 2020 Dec 24;14:100744. doi: 10.1016/j.bonr.2020.100744. eCollection 2021 Jun.
3
Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.经影像引导消融治疗引起骨软化症的持续性磷质间叶性肿瘤。
Osteoporos Int. 2021 Sep;32(9):1895-1898. doi: 10.1007/s00198-020-05795-1. Epub 2021 Mar 2.
4
Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.在孤立性骨纤维发育不良中,FGF23的表达与血清磷酸盐水平相关。
Life Sci. 2006 Apr 11;78(20):2295-301. doi: 10.1016/j.lfs.2005.09.052. Epub 2005 Dec 7.
5
Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.颅内磷酸盐尿性间叶性肿瘤。病例报告及文献复习。
Neuropathology. 2022 Oct;42(5):453-458. doi: 10.1111/neup.12817. Epub 2022 Jul 26.
6
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.一例罕见的沿腱鞘多发磷尿性间叶肿瘤致骨软化症病例。
BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.
7
Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria.伴有正常成纤维细胞生长因子23(FGF23)的肿瘤性骨软化症与特发性高钙尿症。
Cureus. 2022 Jan 3;14(1):e20893. doi: 10.7759/cureus.20893. eCollection 2022 Jan.
8
Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.无骨软化性磷酸盐尿性间叶肿瘤:“非磷酸盐尿性”变异型的进一步确认,强调 FGF23 显色原位杂交和 FN1-FGFR1 荧光原位杂交的作用。
Hum Pathol. 2018 Oct;80:94-98. doi: 10.1016/j.humpath.2018.02.022. Epub 2018 Mar 4.
9
The phosphaturic mesenchymal tumor as a cause of oncogenic osteomalacia. Three cases and review of the literature.作为致癌性骨软化症病因的磷酸尿性间叶肿瘤。三例报告并文献复习
Rev Esp Cir Ortop Traumatol (Engl Ed). 2021 Apr 23. doi: 10.1016/j.recot.2020.12.004.
10
Tumor-induced osteomalacia treated with T12 tumor resection.经T12肿瘤切除治疗的肿瘤诱导性骨软化症
Endocrinol Diabetes Metab Case Rep. 2022 Dec 1;2022. doi: 10.1530/EDM-22-0344.

本文引用的文献

1
Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.测定 FGF23 水平以诊断 FGF23 介导的低磷血症。
J Bone Miner Res. 2022 Nov;37(11):2174-2185. doi: 10.1002/jbmr.4702. Epub 2022 Oct 17.
2
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.肿瘤相关性骨软化症:895 例的系统临床综述。
Calcif Tissue Int. 2022 Oct;111(4):367-379. doi: 10.1007/s00223-022-01005-8. Epub 2022 Jul 20.
3
C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23.
C 端而非完整的 FGF23 和 EPO 在 HIF2A 功能获得性突变患者中呈强烈相关性升高:EPO 调节 FGF23 的临床证据。
J Bone Miner Res. 2021 Feb;36(2):315-321. doi: 10.1002/jbmr.4195. Epub 2020 Nov 22.
4
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.成纤维细胞生长因子 23 在磷酸盐、铁代谢和红细胞生成的十字路口。
Nat Rev Nephrol. 2020 Jan;16(1):7-19. doi: 10.1038/s41581-019-0189-5. Epub 2019 Sep 13.
5
Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.FN1-FGFR1 和新型 FN1-FGF1 融合基因在一系列大型磷酸尿素质瘤中的特征。
Mod Pathol. 2016 Nov;29(11):1335-1346. doi: 10.1038/modpathol.2016.137. Epub 2016 Jul 22.
6
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.鉴定一种新型的FN1-FGFR1基因融合作为磷酸尿性间质性肿瘤中的常见事件。
J Pathol. 2015 Mar;235(4):539-45. doi: 10.1002/path.4465. Epub 2015 Jan 7.
7
Recognition of fibrous dysplasia of bone mimicking skeletal metastasis on 18F-FDG PET/CT imaging.骨纤维结构不良在 18F-FDG PET/CT 成像上模拟骨转移瘤的表现。
Skeletal Radiol. 2011 Mar;40(3):295-302. doi: 10.1007/s00256-010-0999-9. Epub 2010 Aug 2.
8
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.FGF23 的 C 端尾部可通过抑制 FGF23-FGFR-Klotho 复合物的形成来缓解低磷血症。
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):407-12. doi: 10.1073/pnas.0902006107. Epub 2009 Dec 4.
9
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.大多数骨软化症相关的间充质肿瘤是单一组织病理学实体:32例分析及文献综述
Am J Surg Pathol. 2004 Jan;28(1):1-30. doi: 10.1097/00000478-200401000-00001.
10
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.骨纤维异常增殖症中的成纤维细胞生长因子-23及其与肾性磷酸盐消耗的关系。
J Clin Invest. 2003 Sep;112(5):683-92. doi: 10.1172/JCI18399.